 | • レポートコード：C-GIR20G2632 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ダビガトランの世界市場2019年」は、グローバルにおけるダビガトラン市場を展望するレポートです。ダビガトランのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ダビガトランの市場概観 ・ダビガトランの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ダビガトランの企業別販売動向、市場シェア、市場集中度、競争動向 ・ダビガトランの世界市場規模 ・ダビガトランの北米市場分析（アメリカ、カナダ、メキシコ等） ・ダビガトランのアメリカ市場規模推移 ・ダビガトランのカナダ市場規模推移 ・ダビガトランのメキシコ市場規模推移 ・ダビガトランのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ダビガトランのドイツ市場規模推移 ・ダビガトランのイギリス市場規模推移 ・ダビガトランのロシア市場規模推移 ・ダビガトランのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ダビガトランの日本市場規模推移 ・ダビガトランの中国市場規模推移 ・ダビガトランの韓国市場規模推移 ・ダビガトランのインド市場規模推移 ・ダビガトランの東南アジア市場規模推移 ・ダビガトランの南米市場分析（ブラジル、アルゼンチン等） ・ダビガトランの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ダビガトランの種類別分析/販売量、売上、市場シェア（タブレット、カプセル、その他） ・ダビガトランの用途別分析/市場規模（深部静脈血栓症、肺塞栓症、その他） ・ダビガトランの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ダビガトランの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Dabigatran market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Dabigatran.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Dabigatran market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Dabigatran market by product type and applications/end industries.
Market Segment by Companies, this report covers
Teva Pharmaceutical Industries
Boehringer Ingelheim
Bayer Healthcare
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb Company
Aspen Holdings
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Capsule
Others
Market Segment by Applications, can be divided into
Deep Vein Thrombosis
Pulmonary Embolism
Others
Table of Contents
1 Dabigatran Market Overview
1.1 Product Overview and Scope of Dabigatran
1.2 Classification of Dabigatran by Types
1.2.1 Global Dabigatran Revenue Comparison by Types (2019-2024)
1.2.2 Global Dabigatran Revenue Market Share by Types in 2018
1.2.3 Tablets
1.2.4 Capsule
1.2.5 Others
1.3 Global Dabigatran Market by Application
1.3.1 Global Dabigatran Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Deep Vein Thrombosis
1.3.3 Pulmonary Embolism
1.3.4 Others
1.4 Global Dabigatran Market by Regions
1.4.1 Global Dabigatran Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Dabigatran Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Dabigatran Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Dabigatran Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Dabigatran Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Dabigatran Status and Prospect (2014-2024)
1.5 Global Market Size of Dabigatran (2014-2024)
2 Company Profiles
2.1 Teva Pharmaceutical Industries
2.1.1 Business Overview
2.1.2 Dabigatran Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Pharmaceutical Industries Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Dabigatran Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer Healthcare
2.3.1 Business Overview
2.3.2 Dabigatran Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Healthcare Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Dabigatran Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Dabigatran Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bristol-Myers Squibb Company
2.6.1 Business Overview
2.6.2 Dabigatran Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Company Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
2.7 Aspen Holdings
2.7.1 Business Overview
2.7.2 Dabigatran Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aspen Holdings Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
3 Global Dabigatran Market Competition, by Players
3.1 Global Dabigatran Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Dabigatran Players Market Share
3.2.2 Top 10 Dabigatran Players Market Share
3.3 Market Competition Trend
4 Global Dabigatran Market Size by Regions
4.1 Global Dabigatran Revenue and Market Share by Regions
4.2 North America Dabigatran Revenue and Growth Rate (2014-2019)
4.3 Europe Dabigatran Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Dabigatran Revenue and Growth Rate (2014-2019)
4.5 South America Dabigatran Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Dabigatran Revenue and Growth Rate (2014-2019)
5 North America Dabigatran Revenue by Countries
5.1 North America Dabigatran Revenue by Countries (2014-2019)
5.2 USA Dabigatran Revenue and Growth Rate (2014-2019)
5.3 Canada Dabigatran Revenue and Growth Rate (2014-2019)
5.4 Mexico Dabigatran Revenue and Growth Rate (2014-2019)
6 Europe Dabigatran Revenue by Countries
6.1 Europe Dabigatran Revenue by Countries (2014-2019)
6.2 Germany Dabigatran Revenue and Growth Rate (2014-2019)
6.3 UK Dabigatran Revenue and Growth Rate (2014-2019)
6.4 France Dabigatran Revenue and Growth Rate (2014-2019)
6.5 Russia Dabigatran Revenue and Growth Rate (2014-2019)
6.6 Italy Dabigatran Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Dabigatran Revenue by Countries
7.1 Asia-Pacific Dabigatran Revenue by Countries (2014-2019)
7.2 China Dabigatran Revenue and Growth Rate (2014-2019)
7.3 Japan Dabigatran Revenue and Growth Rate (2014-2019)
7.4 Korea Dabigatran Revenue and Growth Rate (2014-2019)
7.5 India Dabigatran Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Dabigatran Revenue and Growth Rate (2014-2019)
8 South America Dabigatran Revenue by Countries
8.1 South America Dabigatran Revenue by Countries (2014-2019)
8.2 Brazil Dabigatran Revenue and Growth Rate (2014-2019)
8.3 Argentina Dabigatran Revenue and Growth Rate (2014-2019)
8.4 Colombia Dabigatran Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Dabigatran by Countries
9.1 Middle East and Africa Dabigatran Revenue by Countries (2014-2019)
9.2 Saudi Arabia Dabigatran Revenue and Growth Rate (2014-2019)
9.3 UAE Dabigatran Revenue and Growth Rate (2014-2019)
9.4 Egypt Dabigatran Revenue and Growth Rate (2014-2019)
9.5 Nigeria Dabigatran Revenue and Growth Rate (2014-2019)
9.6 South Africa Dabigatran Revenue and Growth Rate (2014-2019)
10 Global Dabigatran Market Segment by Type
10.1 Global Dabigatran Revenue and Market Share by Type (2014-2019)
10.2 Global Dabigatran Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2014-2024)
10.4 Capsule Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Dabigatran Market Segment by Application
11.1 Global Dabigatran Revenue Market Share by Application (2014-2019)
11.2 Dabigatran Market Forecast by Application (2019-2024)
11.3 Deep Vein Thrombosis Revenue Growth (2014-2019)
11.4 Pulmonary Embolism Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Dabigatran Market Size Forecast (2019-2024)
12.1 Global Dabigatran Market Size Forecast (2019-2024)
12.2 Global Dabigatran Market Forecast by Regions (2019-2024)
12.3 North America Dabigatran Revenue Market Forecast (2019-2024)
12.4 Europe Dabigatran Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Dabigatran Revenue Market Forecast (2019-2024)
12.6 South America Dabigatran Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Dabigatran Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Dabigatran Picture
Table Product Specifications of Dabigatran
Table Global Dabigatran and Revenue (Million USD) Market Split by Product Type
Figure Global Dabigatran Revenue Market Share by Types in 2018
Figure Tablets Picture
Figure Capsule Picture
Figure Others Picture
Table Global Dabigatran Revenue (Million USD) by Application (2014-2024)
Figure Dabigatran Revenue Market Share by Applications in 2018
Figure Deep Vein Thrombosis Picture
Figure Pulmonary Embolism Picture
Figure Others Picture
Table Global Market Dabigatran Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Dabigatran Revenue (Million USD) and Growth Rate (2014-2024)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Dabigatran Type and Applications
Table Teva Pharmaceutical Industries Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Dabigatran Type and Applications
Table Boehringer Ingelheim Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table Bayer Healthcare Dabigatran Type and Applications
Table Bayer Healthcare Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Dabigatran Type and Applications
Table Pfizer Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Dabigatran Type and Applications
Table GlaxoSmithKline Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Dabigatran Type and Applications
Table Bristol-Myers Squibb Company Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Aspen Holdings Basic Information, Manufacturing Base and Competitors
Table Aspen Holdings Dabigatran Type and Applications
Table Aspen Holdings Dabigatran Revenue, Gross Margin and Market Share (2017-2018)
Table Global Dabigatran Revenue (Million USD) by Players (2014-2019)
Table Global Dabigatran Revenue Share by Players (2014-2019)
Figure Global Dabigatran Revenue Share by Players in 2017
Figure Global Dabigatran Revenue Share by Players in 2018
Figure Global Top 5 Players Dabigatran Revenue Market Share in 2018
Figure Global Top 10 Players Dabigatran Revenue Market Share in 2018
Figure Global Dabigatran Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Dabigatran Revenue (Million USD) by Regions (2014-2019)
Table Global Dabigatran Revenue Market Share by Regions (2014-2019)
Figure Global Dabigatran Revenue Market Share by Regions (2014-2019)
Figure Global Dabigatran Revenue Market Share by Regions in 2018
Figure North America Dabigatran Revenue and Growth Rate (2014-2019)
Figure Europe Dabigatran Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Dabigatran Revenue and Growth Rate (2014-2019)
Figure South America Dabigatran Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Dabigatran Revenue and Growth Rate (2014-2019)
Table North America Dabigatran Revenue by Countries (2014-2019)
Table North America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure North America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure North America Dabigatran Revenue Market Share by Countries in 2018
Figure USA Dabigatran Revenue and Growth Rate (2014-2019)
Figure Canada Dabigatran Revenue and Growth Rate (2014-2019)
Figure Mexico Dabigatran Revenue and Growth Rate (2014-2019)
Table Europe Dabigatran Revenue (Million USD) by Countries (2014-2019)
Figure Europe Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Europe Dabigatran Revenue Market Share by Countries in 2018
Figure Germany Dabigatran Revenue and Growth Rate (2014-2019)
Figure UK Dabigatran Revenue and Growth Rate (2014-2019)
Figure France Dabigatran Revenue and Growth Rate (2014-2019)
Figure Russia Dabigatran Revenue and Growth Rate (2014-2019)
Figure Italy Dabigatran Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Dabigatran Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Dabigatran Revenue Market Share by Countries in 2018
Figure China Dabigatran Revenue and Growth Rate (2014-2019)
Figure Japan Dabigatran Revenue and Growth Rate (2014-2019)
Figure Korea Dabigatran Revenue and Growth Rate (2014-2019)
Figure India Dabigatran Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Dabigatran Revenue and Growth Rate (2014-2019)
Table South America Dabigatran Revenue by Countries (2014-2019)
Table South America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure South America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure South America Dabigatran Revenue Market Share by Countries in 2018
Figure Brazil Dabigatran Revenue and Growth Rate (2014-2019)
Figure Argentina Dabigatran Revenue and Growth Rate (2014-2019)
Figure Colombia Dabigatran Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Dabigatran Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dabigatran Revenue Market Share by Countries in 2018
Figure Saudi Arabia Dabigatran Revenue and Growth Rate (2014-2019)
Figure UAE Dabigatran Revenue and Growth Rate (2014-2019)
Figure Egypt Dabigatran Revenue and Growth Rate (2014-2019)
Figure Nigeria Dabigatran Revenue and Growth Rate (2014-2019)
Figure South Africa Dabigatran Revenue and Growth Rate (2014-2019)
Table Global Dabigatran Revenue (Million USD) by Type (2014-2019)
Table Global Dabigatran Revenue Share by Type (2014-2019)
Figure Global Dabigatran Revenue Share by Type (2014-2019)
Figure Global Dabigatran Revenue Share by Type in 2018
Table Global Dabigatran Revenue Forecast by Type (2019-2024)
Figure Global Dabigatran Market Share Forecast by Type (2019-2024)
Figure Global Tablets Revenue Growth Rate (2014-2019)
Figure Global Capsule Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Dabigatran Revenue by Application (2014-2019)
Table Global Dabigatran Revenue Share by Application (2014-2019)
Figure Global Dabigatran Revenue Share by Application (2014-2019)
Figure Global Dabigatran Revenue Share by Application in 2018
Table Global Dabigatran Revenue Forecast by Application (2019-2024)
Figure Global Dabigatran Market Share Forecast by Application (2019-2024)
Figure Global Deep Vein Thrombosis Revenue Growth Rate (2014-2019)
Figure Global Pulmonary Embolism Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Dabigatran Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Dabigatran Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Dabigatran Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Dabigatran Revenue Market Forecast (2019-2024)
Figure Europe Dabigatran Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Dabigatran Revenue Market Forecast (2019-2024)
Figure South America Dabigatran Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Dabigatran Revenue Market Forecast (2019-2024)
血栓溶解療法の世界市場 2019年版：種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中） Scope of the Report: The global Thrombolytic Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also…- 世界の末梢静脈血栓除去デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Peripheral Venous Thrombectomy Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the …
- 世界の末梢静脈血栓除去デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Peripheral Venous Thrombectomy Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the …
- 世界の肺水腫治療市場予測（～2024年） Pulmonary edema refers to the generation and reflux imbalance of tissue fluid in the lung caused by some reasons, so that a large number of tissue fluid in a very short period of time can not be absorbed by the pulmonary lymphatic and pulmonary vein system, from the pulmonary capillary osmosis, accu…
- 急性虚血性脳卒中薬の世界市場 2019年版：種類別（タブレット、カプセル、その他）、用途別（タブレット、カプセル、その他） Scope of the Report: The global Acute Ischemic Stroke Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chin…